Article
Benchmarking genome-wide association study causal gene prioritization for drug discovery
2025-09-25
Abstract excerpt
Drug discovery is costly, with billions spent on failed trials. Drugs with genetic support from genome-wide association studies (GWAS) have substantially greater odds of success, but how best to use GWAS to prioritize drug targets remains unclear. We evaluated the performance of GWAS causal gene prioritization methods from the Open Targets consortium by cross-referencing their predictions with drug trial outcomes...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 98efef94-ab8d-50ef-b5a6-995aaa429ac4
- DOI
- 10.1101/2025.09.23.25336370
